| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 |
Revenue  | 152 | 123 | 115 | 119 | 132 | 142 | 111 | 143 | 153 | 139 | 150 | 210 | 241 | 185 | 211 | 242 | 273 | 261 | 223 | 275 | 296 | 306 | 258 | 299 | 329 | 341 | 312 | 386 | 411 | 385 | 486 | 398 | 429 | 426 | 408 | 388 | 408 | 398 | 436 | 435 |
| Expenses | 120 | 94 | 99 | 106 | 104 | 122 | 94 | 132 | 158 | 150 | 142 | 202 | 221 | 168 | 184 | 226 | 251 | 225 | 192 | 244 | 259 | 255 | 223 | 251 | 276 | 285 | 289 | 326 | 365 | 337 | 428 | 338 | 393 | 381 | 381 | 363 | 465 | 378 | 531 | 387 |
| EBITDA | 32 | 29 | 16 | 14 | 28 | 21 | 17 | 11 | -6 | -11 | 8 | 8 | 19 | 18 | 27 | 16 | 21 | 36 | 31 | 30 | 37 | 52 | 35 | 48 | 53 | 56 | 23 | 61 | 46 | 48 | 58 | 60 | 36 | 45 | 27 | 25 | -57 | 20 | -95 | 48 |
| Operating Profit % | 17 % | 23 % | 13 % | 11 % | 21 % | 11 % | 16 % | 1 % | -5 % | -8 % | 3 % | 3 % | 5 % | 8 % | 9 % | 6 % | 6 % | 14 % | 14 % | 11 % | 12 % | 17 % | 13 % | 16 % | 15 % | 14 % | 7 % | 14 % | 6 % | 12 % | 11 % | 13 % | 8 % | 9 % | 6 % | 6 % | -16 % | 5 % | -25 % | 11 % |
| Depreciation | 5 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 5 | 6 | 6 | 10 | 7 | 8 | 7 | 7 | 8 | 8 | 8 | 9 | 10 | 10 | 13 | 12 | 13 | 13 | 13 | 16 | 14 | 14 | 16 | 18 | 19 | 19 | 21 | 20 | 20 | 21 | 15 |
| Interest | 7 | 6 | 6 | 6 | 7 | 7 | 6 | 9 | 5 | 6 | 8 | 10 | 4 | 9 | 10 | 11 | 7 | 6 | 14 | 8 | 15 | 11 | 8 | 7 | 12 | 10 | 9 | 7 | 10 | 19 | 19 | 12 | 10 | 10 | 20 | 14 | 16 | 23 | 26 | 34 |
| Profit Before Tax | 20 | 20 | 8 | 5 | 17 | 9 | 6 | -3 | -17 | -22 | -6 | -8 | 5 | 2 | 10 | -2 | 7 | 23 | 9 | 14 | 13 | 32 | 17 | 28 | 29 | 33 | 1 | 41 | 20 | 15 | 26 | 32 | 8 | 16 | -12 | -10 | -94 | -24 | -142 | -0 |
| Tax | -3 | 6 | 3 | 2 | 3 | 6 | 5 | 0 | -12 | -10 | -3 | -3 | 10 | 6 | 8 | -1 | 0 | 6 | 1 | 10 | 11 | 11 | 8 | 8 | 13 | 9 | 5 | 14 | 7 | 11 | 16 | 9 | 5 | 4 | 9 | 5 | -12 | 11 | -26 | 7 |
| Net Profit | 23 | 14 | 5 | 3 | 14 | 3 | 1 | -4 | -5 | -11 | -3 | -5 | -4 | -4 | 2 | -1 | 6 | 16 | 8 | 4 | 2 | 21 | 10 | 19 | 16 | 24 | -4 | 27 | 13 | 4 | 10 | 23 | 4 | 12 | -21 | -14 | -82 | -35 | -116 | -8 |
| EPS in ₹ | 0.47 | 1.45 | 0.53 | 0.27 | 1.48 | 0.12 | 0.07 | -0.33 | -0.85 | -1.16 | -0.40 | -1.36 | -0.66 | -0.49 | 0.11 | -0.17 | 0.60 | 1.28 | 0.57 | 0.43 | 0.22 | 1.27 | 0.49 | 1.26 | 1.16 | 1.75 | -0.43 | 2.25 | 1.16 | 0.37 | 0.83 | 1.53 | 0.59 | 0.96 | -1.17 | -0.71 | -4.64 | -2.03 | -5.98 | -0.24 |
Camlin Fine Sciences
169.55
-0.91
(-0.53%)
There are 2 new updates from the company12 hours ago
View
Market Cap
3,186.20 Cr
EPS
-5.58
PE Ratio
-
Dividend Yield
0.00 %
Industry
Chemicals52 Week High
180.86
52 Week Low
78.11
PB Ratio
3.68
Debt to Equity
0.94
Sector
Specialty Chemicals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
Peer Comparison Compare Peers on Screener
| Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
3,066.90 | #1 1,55,997.12 | 76.84 | 12,522.60 | #1 5.69 | #1 1,747 | 9.04 | 74.72 | |
3,000.60 | 88,945.23 | 77.84 | 13,221.50 | -11.53 | 1,336 | 6.99 | 56.71 | |
3,971.00 | 43,621.44 | 95.35 | 4,387.70 | -25.09 | 435 | 57.50 | 57.90 | |
2,013.70 | 27,465.47 | 40.01 | 7,757.90 | -3.26 | 811 | -51.46 | 53.75 | |
467.05 | 23,057.38 | 42.76 | 4,227.40 | 0.66 | 411 | 34.98 | 57.29 | |
4,311.00 | 21,371.15 | 80.43 | 2,120.90 | 0.37 | 271 | 7.18 | 60.67 | |
4,600.40 | 19,913.13 | #1 33.40 | #1 13,843.30 | - | 563 | -26.05 | 55.48 | |
6,213.00 | 18,292.16 | 42.70 | 4,783.90 | -13.69 | 324 | #1 62.41 | 62.99 | |
1,669.90 | 17,311.12 | 44.72 | 1,938.80 | -8.77 | 323 | 21.85 | 62.43 | |
432.85 | 15,691.67 | 43.10 | 6,380.70 | -3.61 | 417 | -62.90 | 62.93 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
-3.48 %
Net Income Growth
-363.57 %
Cash Flow Change
173.05 %
ROE
-353.42 %
ROCE
-129.11 %
EBITDA Margin (Avg.)
-56.12 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 430 | 483 | 673 | 1,017 | 1,087 | 1,234 | 1,482 | 1,800 | 2,060 | 1,952 |
| Fixed Assets | 106 | 140 | 201 | 278 | 272 | 306 | 584 | 601 | 858 | 816 |
| Current Assets | 299 | 300 | 419 | 666 | 673 | 675 | 795 | 894 | 1,088 | 1,001 |
| Capital Work in Progress | 3 | 25 | 8 | 14 | 59 | 179 | 24 | 215 | 43 | 46 |
| Investments | 0 | 0 | 19 | 115 | 11 | 7 | 7 | 7 | 8 | 8 |
| Other Assets | 320 | 317 | 445 | 609 | 745 | 742 | 867 | 977 | 1,152 | 1,082 |
| Total Liabilities | 430 | 483 | 673 | 1,017 | 1,087 | 1,234 | 1,482 | 1,800 | 2,060 | 1,952 |
| Current Liabilities | 262 | 280 | 386 | 471 | 460 | 548 | 478 | 595 | 793 | 732 |
| Non Current Liabilities | 33 | 27 | 57 | 112 | 196 | 226 | 291 | 440 | 443 | 363 |
| Total Equity | 135 | 176 | 230 | 433 | 430 | 460 | 713 | 765 | 824 | 857 |
| Reserve & Surplus | 125 | 167 | 202 | 359 | 355 | 388 | 582 | 729 | 800 | 845 |
| Share Capital | 10 | 10 | 10 | 12 | 12 | 12 | 13 | 16 | 16 | 17 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 5 | -1 | 13 | 18 | 15 | -1 | 23 | 32 | -14 | -14 |
| Investing Activities | -26 | -66 | -70 | -149 | -2 | -90 | -133 | -249 | -125 | -67 |
| Operating Activities | 46 | 72 | -9 | -15 | -9 | 86 | 117 | 145 | 51 | 139 |
| Financing Activities | -16 | -7 | 91 | 182 | 26 | 3 | 39 | 136 | 60 | -86 |
Share Holding
| % Holding | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Jan 2025 | Mar 2025 |
| Promoter | 41.14 % | 41.14 % | 40.95 % | 40.96 % | 40.93 % | 35.06 % | 22.37 % | 22.39 % | 22.49 % | 22.66 % | 22.66 % | 22.66 % | 22.70 % | 22.85 % | 22.85 % | 22.85 % | 22.84 % | 21.74 % | 21.73 % | 21.71 % | 21.71 % | 21.71 % | 17.65 % | 17.64 % | 17.64 % | 17.64 % | 17.64 % | 16.52 % | 48.03 % | 48.03 % | 48.03 % | 48.02 % | 48.02 % | 48.02 % | 49.10 % | 49.10 % |
| FIIs | 8.75 % | 7.00 % | 7.56 % | 7.76 % | 2.54 % | 2.29 % | 4.73 % | 4.26 % | 1.30 % | 1.37 % | 1.25 % | 1.12 % | 0.93 % | 0.89 % | 1.22 % | 1.16 % | 1.75 % | 1.71 % | 4.71 % | 5.28 % | 5.01 % | 4.81 % | 10.50 % | 10.74 % | 11.32 % | 10.94 % | 10.18 % | 0.00 % | 0.00 % | 0.00 % | 1.69 % | 1.01 % | 0.81 % | 0.76 % | 0.82 % | 1.47 % |
| DIIs | 2.81 % | 3.42 % | 4.69 % | 5.02 % | 6.72 % | 16.82 % | 18.49 % | 19.25 % | 19.97 % | 19.04 % | 19.02 % | 19.13 % | 21.23 % | 21.41 % | 21.06 % | 18.97 % | 18.99 % | 20.34 % | 20.21 % | 19.71 % | 19.03 % | 17.88 % | 14.47 % | 14.20 % | 13.53 % | 12.53 % | 12.33 % | 9.31 % | 2.74 % | 2.75 % | 4.54 % | 4.89 % | 4.24 % | 3.39 % | 4.09 % | 3.83 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.40 % | 0.40 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.03 % | 0.03 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 29.94 % | 28.56 % | 28.28 % | 27.57 % | 28.29 % | 26.07 % | 30.94 % | 31.32 % | 33.29 % | 34.51 % | 34.76 % | 35.09 % | 36.61 % | 34.30 % | 34.45 % | 35.65 % | 35.89 % | 33.57 % | 31.21 % | 35.11 % | 35.68 % | 36.69 % | 30.32 % | 30.77 % | 30.32 % | 31.31 % | 31.30 % | 30.41 % | 33.23 % | 34.18 % | 32.75 % | 33.89 % | 34.52 % | 35.13 % | 33.14 % | 32.85 % |
| Others | 17.36 % | 19.88 % | 18.52 % | 18.69 % | 21.53 % | 19.36 % | 23.07 % | 22.78 % | 22.95 % | 22.42 % | 22.30 % | 22.00 % | 18.53 % | 20.56 % | 20.42 % | 21.37 % | 20.53 % | 22.65 % | 22.14 % | 18.18 % | 18.56 % | 18.91 % | 27.05 % | 26.65 % | 27.19 % | 27.57 % | 28.51 % | 43.72 % | 16.00 % | 15.04 % | 12.99 % | 12.19 % | 12.41 % | 12.70 % | 12.85 % | 12.75 % |
| No of Share Holders | 30,639 | 28,337 | 29,209 | 29,101 | 29,767 | 26,478 | 31,972 | 34,096 | 36,498 | 36,717 | 35,885 | 35,285 | 33,154 | 33,849 | 41,630 | 43,139 | 39,500 | 40,599 | 38,712 | 41,543 | 51,038 | 56,394 | 55,277 | 57,835 | 57,904 | 54,197 | 52,921 | 52,278 | 57,098 | 62,098 | 58,165 | 62,687 | 67,750 | 61,893 | 60,554 | 58,111 |
Dividend History
Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
Login to View
This information is available only for users of ScanX and Dhan.To proceed ahead,
LoginOpen Account
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
12 hours ago
12 hours agoShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot12 hours ago
12 hours agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 26, 2025
Mar 26, 2025Closure of Trading WindowMar 26, 2025
Mar 26, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 25, 2025
Mar 25, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 24, 2025
Mar 24, 2025Update On Analyst / Institutional Investor MeetingMar 18, 2025
Mar 18, 2025Update On Joint Press ReleaseMar 13, 2025
Mar 13, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2025
Mar 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMar 12, 2025
Mar 12, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2025
Mar 12, 2025Update On Press ReleaseFeb 25, 2025
Feb 25, 2025Update On Press ReleaseFeb 25, 2025
Feb 25, 2025Disclosure Pursuant To Clause 5 Of Para B Of Part A Of Schedule III Of SEBI LODR Regulations 2015
Feb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-AcquisitionFeb 24, 2025
Feb 24, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 19, 2025
Feb 19, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Feb 17, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2025
Feb 14, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Feb 14, 2025Board Meeting Outcome for Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And
Nine Months Ended December 31 2024Feb 14, 2025
Feb 14, 2025Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Feb 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Feb 11, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 08, 2025
Feb 08, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 06, 2025
Feb 06, 2025Board Meeting Intimation for Intimation About The Board Meeting Of Camlin Fine Sciences Limited (The Company) To Be Held On February 14 2025Feb 06, 2025
Feb 06, 2025Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The Asst./DFeb 05, 2025
Feb 05, 2025Announcement under Regulation 30 (LODR)-Change in ManagementFeb 05, 2025
Feb 05, 2025Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Update On Intimation Made Regarding Receipt Of Closure Direction FoFeb 01, 2025
Feb 01, 2025Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The CommissFeb 01, 2025
Feb 01, 2025Announcement under Regulation 30 (LODR)-AllotmentJan 31, 2025
Jan 31, 2025Board Meeting Outcome for Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of
Directors Of Camlin Fine Sciences LimitedJan 31, 2025
Jan 31, 2025ClarificationJan 22, 2025
Jan 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 20, 2025
Jan 20, 2025Announcement under Regulation 30 (LODR)-Strikes /Lockouts / DisturbancesJan 18, 2025
Jan 18, 2025Intimation Regarding Receipt Of Closure Direction For Our Unit Situated At SEZ Dahej Bharuch.Jan 18, 2025
Jan 18, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 15, 2025
Jan 15, 2025Regulation 30 And Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations): Intimation Regarding Receipt Of An Order From Office Of The CommissJan 14, 2025
Jan 14, 2025Board Meeting Outcome for Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors Of Camlin Fine Sciences Limited (The Company) Held On January 9 2025Jan 09, 2025
Jan 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Jan 06, 2025Intimation Regarding Change In The Name Of Registrar And Share Transfer Agent (RTA) Of Camlin Fine Sciences Limited (The Company).Jan 03, 2025
Jan 03, 2025Rights Issue - Record Date Is Wednesday January 8 2025Jan 02, 2025
Jan 02, 2025Announcement under Regulation 30 (LODR)-Raising of FundsJan 02, 2025
Jan 02, 2025Board Meeting Outcome for Outcome Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors Of Camlin Fine Sciences Limited (The Company) Held On January 2 2025.Jan 02, 2025
Jan 02, 2025Board Meeting Intimation for Intimation Of The Meeting Of The Securities Issue And Allotment Committee Of The Board Of Directors To Be Held On Thursday January 2 2025.Dec 30, 2024
Dec 30, 2024Announcement under Regulation 30 (LODR)-Change in ManagementDec 16, 2024
Dec 16, 2024Update For An Announcement Made Under Regulation 30 (LODR)-Change In Management Dated November 11, 2024Dec 13, 2024
Dec 13, 2024Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011Dec 11, 2024
Dec 11, 2024Technical Indicators
RSI(14)
Neutral 56.04
ATR(14)
Less Volatile 10.21
STOCH(9,6)
Overbought 86.59
STOCH RSI(14)
Overbought 84.88
MACD(12,26)
Bullish 0.82
ADX(14)
Strong Trend 25.50
UO(9)
Bearish 60.12
ROC(12)
Downtrend And Accelerating -1.65
WillR(14)
Overbought -11.59
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
